KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Treasury Shares: 2013-2025

Historic Treasury Shares for TherapeuticsMD (TXMD) over the last 5 years, with Mar 2025 value amounting to $5,000.

  • TherapeuticsMD's Treasury Shares rose 13057.89% to $5,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $5,000, marking a year-over-year increase of 13057.89%. This contributed to the annual value of $5,000 for FY2024, which is 87.50% down from last year.
  • Latest data reveals that TherapeuticsMD reported Treasury Shares of $5,000 as of Q1 2025, which was down 0.00% from $5,000 recorded in Q4 2024.
  • TherapeuticsMD's 5-year Treasury Shares high stood at $16.1 million for Q3 2021, and its period low was $38 during Q1 2024.
  • Moreover, its 3-year median value for Treasury Shares was $38,000 (2024), whereas its average is $53,115.
  • As far as peak fluctuations go, TherapeuticsMD's Treasury Shares spiked by 20,855.88% in 2022, and later tumbled by 99.98% in 2024.
  • Over the past 5 years, TherapeuticsMD's Treasury Shares (Quarterly) stood at $272 in 2021, then soared by 20,855.88% to $57,000 in 2022, then decreased by 29.82% to $40,000 in 2023, then slumped by 87.50% to $5,000 in 2024, then soared by 13,057.89% to $5,000 in 2025.
  • Its last three reported values are $5,000 in Q1 2025, $5,000 for Q4 2024, and $5,000 during Q3 2024.